Cathy Young, FNP, inducted into Dunklin County Hall of Fame
Dr. Cathy Young … earned a post-masters degree from the University of Tennessee Health Science Center, as a Family Nurse Practitioner (FNP).
UTHSC In the Media
Dr. Voeller Weighs in on Hernia Mesh Debate
Guy Voeller, MD, FACS, the chair of the panel, defended the use of mesh. “Mesh has helped many people,” Dr. Voeller, professor of surgery at the University of Tennessee Health Science Center (UTHSC), in Memphis, told GSN.
UTHSC shares master plan for Memphis campus
A new campus master plan for the University of Tennessee Health Science Center will take center stage on Monday, Oct. 27, during an open house for those on the Memphis Medical Center campus as well as for the public. Representatives of the Perkins + Will firm will discuss the master plan for campus buildings and other… Read More
UTHSC Alum Runs for Office
Bob Proffitt, a graduate of the UT College of Medicine, former army physician in Seoul, South Korea, for the American Embassy and the State Department, is seeking the Maryville City School Board of Education.
Dr. Jon McCullers Compares H1N1 Five Years Ago with Ebola Today
“Memphis was the epicenter for that,” said Dr. Jon McCullers, pediatrician in chief for Le Bonheur and chairman of the pediatrics department at the University of Tennessee Health Science Center. “We dealt with that then. I think we are appropriately prepared to deal with this now.”
First Black Medical Student Returns to UTHSC
Dr. Alvin Crawford and Dr. Doug Wilson had an instant friendship, and they never let segregation affect it.
UTHSC Pharmacy Students Give Flu Shots
College of Pharmacy students at the University of Tennessee Health Science Center are giving free flu shots to homeless people who participate in a community outreach program in Memphis. The school’s American Pharmacists Association Academy of Student Pharmacists chapter was given a $3,000 grant last year to help vaccinate people with reduced incomes in Memphis.
Dr. DeVincenzo Studies Respiratory Syncytial Virus (RSV)
John DeVincenzo, MD, of the department of pediatrics at the University of Tennessee Health Science Center in Memphis, Tenn., said the current double blind, placebo-controlled phase 2 study aimed to evaluate ALS‑008176, an oral nucleoside analogue that causes nascent RNA chain-termination, thereby inhibiting RSV replication.